v3.26.1
Condensed Consolidated Statements of Shareholders' Deficit (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings, Appropriated [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2024 42,231,746        
Balance at Dec. 31, 2024 $ 115 $ 797,248 $ (806,222) $ 56 $ (8,803)
Exercise of options into ordinary shares (in shares) 288,925        
Exercise of options into ordinary shares $ 1 29     30
Share-based compensation   3,069     3,069
Other comprehensive loss (42) (42)
Net loss     (43,843)   (43,843)
Conversion of pre-funded warrants into ordinary shares (in shares) 3,206,271        
Conversion of pre-funded warrants into ordinary shares $ 9 (6) 3
Issuance of ordinary shares, net of issuance costs (in shares) 374,843        
Issuance of ordinary shares, net of issuance costs $ 1 3,127     3,128
Balance (in shares) at Mar. 31, 2025 46,101,785        
Balance at Mar. 31, 2025 $ 126 803,467 (850,065) 14 (46,458)
Balance (in shares) at Dec. 31, 2025 48,350,272        
Balance at Dec. 31, 2025 $ 133 854,090 (959,716) 19 (105,474)
Exercise of options into ordinary shares (in shares) 358,008        
Exercise of options into ordinary shares $ 1 178     179
Share-based compensation   4,627     4,627
Other comprehensive loss (11) (11)
Net loss     (23,574)   (23,574)
Balance (in shares) at Mar. 31, 2026 48,708,280        
Balance at Mar. 31, 2026 $ 134 $ 858,895 $ (983,290) $ 8 $ (124,253)